Stocks · News reference
Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 50 percent increase over losses of $(0.60) per share from
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-12 AccNo: 0001193125-26-345722 Size: 18 MB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarU.S. stock futures mixed, Dow futures up 100 pts. Fermi Inc (FRMI) shares down 20.4% in pre-market along with other stocks declining.
Read original at benzinga